141 related articles for article (PubMed ID: 31016803)
1. Long-term effect of methotrexate for childhood atopic dermatitis.
Purvis D; Lee M; Agnew K; Birchall N; Dalziel SR
J Paediatr Child Health; 2019 Dec; 55(12):1487-1491. PubMed ID: 31016803
[TBL] [Abstract][Full Text] [Related]
2. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
Weatherhead SC; Wahie S; Reynolds NJ; Meggitt SJ
Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
[TBL] [Abstract][Full Text] [Related]
4. Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial.
Gerbens LAA; Hamann SAS; Brouwer MWD; Roekevisch E; Leeflang MMG; Spuls PI
Br J Dermatol; 2018 Jun; 178(6):1288-1296. PubMed ID: 29237228
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate for the treatment of adult atopic dermatitis.
Goujon C; Bérard F; Dahel K; Guillot I; Hennino A; Nosbaum A; Saad N; Nicolas JF
Eur J Dermatol; 2006; 16(2):155-8. PubMed ID: 16581567
[TBL] [Abstract][Full Text] [Related]
6. The methotrexate polyglutamate assay supports the efficacy of methotrexate for severe inflammatory skin disease in children.
Rahman SI; Siegfried E; Flanagan KH; Armbrecht ES
J Am Acad Dermatol; 2014 Feb; 70(2):252-6. PubMed ID: 24332314
[TBL] [Abstract][Full Text] [Related]
7. Low dose methotrexate therapy is effective in late-onset atopic dermatitis and idiopathic eczema.
Zoller L; Ramon M; Bergman R
Isr Med Assoc J; 2008 Jun; 10(6):413-4. PubMed ID: 18669134
[TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT).
Irvine AD; Jones AP; Beattie P; Baron S; Browne F; Ashoor F; O'Neill L; Rosala-Hallas A; Sach T; Spowart C; Taams L; Walker C; Wan M; Webb N; Williamson P; Flohr C;
Br J Dermatol; 2018 Dec; 179(6):1297-1306. PubMed ID: 29727479
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.
Wahn U; Bos JD; Goodfield M; Caputo R; Papp K; Manjra A; Dobozy A; Paul C; Molloy S; Hultsch T; Graeber M; Cherill R; de Prost Y;
Pediatrics; 2002 Jul; 110(1 Pt 1):e2. PubMed ID: 12093983
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate for Severe Childhood Atopic Dermatitis: Clinical Experience in a Tertiary Center.
Dvorakova V; O'Regan GM; Irvine AD
Pediatr Dermatol; 2017 Sep; 34(5):528-534. PubMed ID: 28730617
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Patient-Oriented Eczema Measure and Patient-Oriented Scoring Atopic Dermatitis vs Eczema Area and Severity Index and other measures of atopic dermatitis: A validation study.
Silverberg JI; Lei D; Yousaf M; Janmohamed SR; Vakharia PP; Chopra R; Chavda R; Gabriel S; Patel KR; Singam V; Kantor R; Hsu DY
Ann Allergy Asthma Immunol; 2020 Jul; 125(1):78-83. PubMed ID: 32199977
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review.
Roekevisch E; Spuls PI; Kuester D; Limpens J; Schmitt J
J Allergy Clin Immunol; 2014 Feb; 133(2):429-38. PubMed ID: 24269258
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe pediatric atopic dermatitis with methotrexate: A retrospective review.
Anderson K; Putterman E; Rogers RS; Patel D; Treat JR; Castelo-Soccio L
Pediatr Dermatol; 2019 May; 36(3):298-302. PubMed ID: 30811669
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial of methotrexate versus azathioprine for severe atopic eczema.
Schram ME; Roekevisch E; Leeflang MM; Bos JD; Schmitt J; Spuls PI
J Allergy Clin Immunol; 2011 Aug; 128(2):353-9. PubMed ID: 21514637
[TBL] [Abstract][Full Text] [Related]
15. Economic and Humanistic Burden in Paediatric Patients with Atopic Dermatitis.
Achten R; Van der Rijst L; Piena M; Lamers H; De Beer F; De Bruin-Weller M; De Graaf M
Acta Derm Venereol; 2023 Mar; 103():adv00881. PubMed ID: 36883875
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Efficacy and Safety of Methotrexate in Moderate-to-Severe Atopic Dermatitis: A Retrospective Study of Korean Patients at Tertiary Referral Hospital.
Lee JH; Yun SJ; Lee JB; Lee SC
Ann Dermatol; 2020 Oct; 32(5):402-408. PubMed ID: 33911775
[TBL] [Abstract][Full Text] [Related]
17. Systemic Agents for Severe Atopic Dermatitis in Children.
Notaro ER; Sidbury R
Paediatr Drugs; 2015 Dec; 17(6):449-57. PubMed ID: 26547214
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for treatment of atopic dermatitis in children and adolescents.
Deo M; Yung A; Hill S; Rademaker M
Int J Dermatol; 2014 Aug; 53(8):1037-41. PubMed ID: 24602088
[TBL] [Abstract][Full Text] [Related]
19. Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods.
Charman CR; Venn AJ; Ravenscroft JC; Williams HC
Br J Dermatol; 2013 Dec; 169(6):1326-32. PubMed ID: 24024631
[TBL] [Abstract][Full Text] [Related]
20. The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study.
Taieb Y; Baum S; Ben Amitai D; Barzilai A; Greenberger S
J Dermatolog Treat; 2019 May; 30(3):240-244. PubMed ID: 30109960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
